Strategic partnership Waltz Health is an EVERSANA company pursuing direct-to-employer access and partnerships with PBMs to reduce drug costs and improve access. This creates a sales opportunity by positioning complementary technology-enabled pricing and distribution platforms to employers and payers seeking transparency and lower spend on high-cost therapies.

Direct-to-employer push Recent launches of direct-to-employer programs for obesity and weight-loss drugs indicate a strong channel shift away from traditional pharmacy benefit managers. Engage with employers and benefit managers to offer Waltz Health powered pricing and access models for FDA-approved obesity and GLP-1 therapies.

Expanded networks Partnerships such as the True Rx collaboration and the broader EVERSANA integration suggest opportunities to integrate Waltz Health marketplaces with employer health plans and pharmacy networks to drive competition, streamline dispensing, and optimize patient access across payer ecosystems.

Tech-enabled efficiency Waltz Health leverages AI-driven marketplaces and a tech stack including GraphQL, SQL Server, and data tooling (DBT, Jenkins) to enable transparent pricing and agile distribution. This offers a compelling sell to CIOs and IT leaders seeking automation, data integrity, and scalable PBM alternatives.

Financial foothold With reported revenue in the mid tens of millions and $18M in funding, Waltz Health demonstrates growth potential and investor-backed stability. This can reassure buyers about continued product development and reliability of the platform when considering pilots or broader deployments.